Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)

Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China; The Institute of Translational Hepatology, 302 Hospital of PLA, Peking University, Beijing, China; Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China; Institute for Viral Hepatitis, the Key Laboratory of Molecular Biology for Infectious Diseases, the second Affiliated Hospital of Chongqing Medical University, Chongqing, China; Department of Microbiology of Peking University Health Science Center, Beijing, China; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; Serious Illness Medicine Inpatient Area, Beijing Youan Hospital, Capital Medical University, Beijing, China; Department of Pathology, 302 Hospital of PLA, Peking University, Beijing, China; Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, China; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China; Center of Infectious Diseases, West China Hospital of Sichuan University, Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China; Department of Infectious Diseases, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China; Hepatology Institute, Peking University People’s Hospital, Beijing, China